ストックスクリーナーアプリを入手
0.205
8.56%
-0.0192
前日終値:
$0.2242
開ける：
$0.2303
24時間の取引高:
452.82K
Relative Volume:
0.10
時価総額：
$4.08M
収益：
当期純損益:
$1.24B
株価収益率:
0.00805
EPS:
25.475
ネットキャッシュフロー:
$-31.80M
1週間 パフォーマンス:
-19.29%
1か月 パフォーマンス:
-74.73%
6か月 パフォーマンス:
-98.46%
1年 パフォーマンス:
-98.75%
1日の値動き範囲:
$0.2045
$0.2334
1週間の範囲:
$0.2045
$0.2634
52週間の値動き範囲:
$0.2045
$27.15
Enlivex Ltd Stock (ENLV) Company Profile
Compare ENLV vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Ltd
|
0.205 | 4.08M | 0 | 1.24B | -31.80M | 25.48 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Enlivex Ltd Stock (ENLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-02 | 繰り返されました | H.C. Wainwright | Buy |
Enlivex Ltd (ENLV) 最新ニュース
Enlivex Calls October 14 Extraordinary Meeting to Approve 1-for-16 Reverse Share Split - TipRanks
RAIN Token: Enlivex Terminates Its Financing - cryptoticker.io
No operating revenue, yet Enlivex Ltd. (NASDAQ: ENLV) posted a first-half profit. - Stock Titan
Enlivex Therapeutics stock reports cancelled financing - AD HOC NEWS
Crypto token stock sale is dropped at Enlivex (NASDAQ: ENLV) - Stock Titan
A planned 66.7 million-share sale is off. Enlivex will not seek approval. - Stock Titan
Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - finance.yahoo.com
Enlivex Therapeutics Ltd (NASDAQ: ENLV) Stock Price, News & Analysis - kalkine.ca
Enlivex Therapeutics Ltd (NASDAQ: ENLV) Stock Price, News & Analysis - kalkine.com.au
Enlivex (ENLV) Shares Slide 8.5% as Biotech Tests Key Support at $1.28Support Level Bounce - vinanet.vn
Enlivex Therapeutics Ltd.ADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Enlivex (ENLV) Shares Slide 8.5% as Biotech Tests Key Support at $1.28ETF NAV Deviation - dars.gov.et
Enlivex Therapeutics Ltd.ADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Enlivex Ltd expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Enlivex Therapeutics (Ondo Tokenized) - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) to Euro Price Today | Live ENLVon to EUR Converter & Exchange Rate - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) Price | ENLVon Price Today, Live Chart, USD converter, Market Capitalization - CryptoRank
Historical Data for Enlivex Therapeutics (Ondo Tokenized) in USD - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) Analytics - CryptoRank
Enlivex (ENLV) Shares Drop 6.51% to $1.58 as Stock Tests Key $1.50 SupportDealer Gamma - vinanet.vn
Enlivex (ENLV) Shares Drop 6.51% to $1.58 as Stock Tests Key $1.50 SupportDynamic Hedging - dars.gov.et
ENLV Q4 2025 Earnings: Loss of -$117.75 Per Share Massively Misses -$0.459 Estimate; Shares Slip 6.51%New Analyst Coverage - Vinanet
Enlivex Ltd. SEC Filing (Aug 14, 2026) - Stock Titan
Enlivex Ltd. (ENLV) sees 9.99% stake reported via convertible note - Stock Titan
Enlivex Restructures $19.2 Million Convertible Note With Lind, Easing Default Risk - TipRanks
Enlivex (ENLV) revises $21M secured convertible note, adds 10% interest trigger - Stock Titan
Enlivex Therapeutics Ltd (ENLV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ENLV Stockholders Plan Sale of 10 Million Shares Amidst Challenging Valuation Landscape - GuruFocus
Enlivex Ltd. (NASDAQ: ENLV) files to register 10M shares for noteholder resale - Stock Titan
Enlivex (ENLV) Climbs 3.83% to $2.17 as Shares Press Against $2.28 ResistanceVolume Spike Alerts - dars.gov.et
ENLV Maintained by HC Wainwright & Co. -- Price Target Raised to $80 - GuruFocus
H.C. Wainwright Lifts Enlivex Therapeutics (ENLV) Price Target t - GuruFocus
H.C. Wainwright raises Enlivex stock price target to $80 on token gains - Investing.com
Weekly Recap: HC Wainwright & Co. PT hike and Rain Foundation financing - TradingView
ENLV Q4 2025 Earnings: Reported EPS of -117.75 Vastly Misses Estimate, Stock Rises 7.18%Share Repurchase Impact - dars.gov.et
ENLV Q4 2025 Earnings: Reported EPS of -117.75 Vastly Misses Estimate, Stock Rises 7.18% - dars.gov.et
Enlivex Highlights 622% Surge in Rain Protocol Trading Volume to $860 Million - TipRanks
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June - marketscreener.com
Enlivex (Nasdaq: ENLV) Rain protocol volume hits $860M, up 622% - Stock Titan
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June - The Manila Times
Enlivex Ltd. Revenue Breakdown – NASDAQ:ENLV - TradingView
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones - marketscreener.com
Enlivex to Brief Investors on Private Placement, Rain Treasury Strategy and Allocetra RMAT Milestone - TipRanks
Enlivex Ltd. announced that it expects to receive $400 million in funding - marketscreener.com
Enlivex prices USD 400 million private placement at USD 5 per share - Bitget
Enlivex: Price Is $5/Shr for Subscription Amounts Funded in U.S. Dollars, USDT or USD Coin >ENLV - Moomoo
ENLV Stock Slides Into 1-For-15 Reverse Split On Nasdaq - StocksToTrade
Enlivex Ltd (ENLV) 財務データ
収益
当期純利益
現金流量
EPS
4.22%
大文字化:
|
ボリューム (24 時間):